Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Log ind
Få fuld adgang
Devopharma ApS
APS
Active
Reklamebeskyttelse
CVR 38968254
Strandvejen 301, 2920
Charlottenlund
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
·
NACE 7210
Stiftet 2017 · 8 år gammel
— ansatte
Overvåg
Del
Danmark
/
Virksomheder
/
Research and experimental development on natural sciences and engineering
/
Devopharma ApS
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Personer & ejerskab
Ledelse
Nuværende ledelse
Name
Role
Member since
Current (3)
AA
Allan Anesteen Tharuman
Founder
Founder
2017
HN
Henrik Nakskov
Management
Management
2017
SL
Søren Luplau-Pagh
Management
Management
2017
Tidligere (1)
MO
Morten Olesen
Management
Management
2017 – 2019
Bestyrelse
Bestyrelsestilsyn
No data on file.
Aktionærer
Pr. seneste årsrapport
HN HOLDING 2010 ApS — 50–66.65%
Friendly Holding ApS — 25–33.32%
JARCO HOLDING ApS — 15–19.99%
GAIN ApS — 10–14.99%
Allan Anesteen Tharuman — 20–24.99%
Stephan Dr Braun — 25–33.32%
100%
Shareholder
Type
Ownership
Votes
Since
HN HOLDING 2010 ApS
Company
50–66.65%
50–66.65%
2017
Friendly Holding ApS
Company
25–33.32%
25–33.32%
2017
JARCO HOLDING ApS
Company
15–19.99%
15–19.99%
2026
GAIN ApS
Company
10–14.99%
10–14.99%
2026
Allan Anesteen Tharuman
Individual
20–24.99%
20–24.99%
2017
Stephan Dr Braun
Individual
25–33.32%
25–33.32%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Mere om Devopharma ApS
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Regnskaber & nøgletal →
Omsætning, EBITDA, balance og 5-års udvikling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk
